Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis

Bin Wu(Jilin Electric Power Research Institute (China)), Liang Xia(Zhejiang Cancer Hospital), Minghua Ge(Tianjin Medical University Cancer Institute and Hospital), Fang Fěng(Nanjing Medical University), Caixing Sun(Zhejiang Cancer Hospital)
Journal of Experimental & Clinical Cancer Research
May 13, 2015
Cited by 85


Related Papers